Medication
This Professional Care Workers’ Week, we’re recognising and celebrating the people who provide care, compassion and support every day and the difference they make to people living with dementia and those who care for them.
Donanemab: NHS won’t fund new Alzheimer’s drug
Despite disappointment at Donanemab decision, NICE must consider funding to support dementia and carers.
Lecanemab UK license for Alzheimer’s, not recommended by NICE
Lecanemab drug treatment for early Alzheimers is licensed for UK use; NICE must consider funding to support dementia and carers.